Physician

Nitin B Chandramouli, MD

According to 2025 Medicare claims, Nitin Chandramouli, MD (NPI: 1801845730) practices medical oncology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH CANCER SPECIALISTS PC (NPI: 1619925369; TIN: 870519691) and primary practice location at 84106-1494.

Chandramouli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 377 traditional Medicare patients, billed 131,991 HCPCS/CPT codes, and received $2,674,397 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,084 prescription claims across 191 beneficiaries totaling $4,456,382 in drug costs, led by Revlimid (Lenalidomide). DME data shows 47 claims. Open Payments data shows 48 records totaling $936. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,449,480 to $2,674,397. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,869,751 and ending at $4,456,382. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $720 and ending at $1,215.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	436	88,109	$1,449,480
2016	434	121,115	$1,890,825
2017	558	98,050	$1,716,720
2018	533	147,323	$2,308,348
2019	499	122,833	$1,768,475
2020	445	89,840	$1,586,804
2021	515	133,358	$2,396,847
2022	462	118,895	$2,394,694
2023	435	134,235	$2,558,967
2024	377	131,991	$2,674,397

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	158	932	$1,869,751
2016	180	1,093	$2,437,562
2017	159	970	$2,074,631
2018	161	1,028	$2,054,474
2019	172	1,089	$2,070,194
2020	176	1,143	$1,401,518
2021	171	952	$1,945,572
2022	163	950	$2,226,318
2023	168	907	$1,981,665
2024	191	1,084	$4,456,382

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	23	$1,303
2018	N/R	45	$5,610
2019	N/R	15	$1,108
2020	N/R	12	$984
2021	N/R	37	$4,274
2022	N/R	N/R	N/R
2023	N/R	12	$1,367
2024	N/R	47	$3,418

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	177	448	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	165	271	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	173	341	$12
80053	Blood test, comprehensive group of blood chemicals	308	988	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	317	1,105	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	13	350	$1,022,948
Brukinsa	Zanubrutinib	54	1,620	$818,167
Kisqali	Ribociclib Succinate	39	1,092	$551,788
Jakafi	Ruxolitinib Phosphate	20	600	$332,067
Ibrance	Palbociclib	20	560	$316,735

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,649
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$899
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	12	$682
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	11	$187

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$936	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$7,071	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Nitin B. Chandramouli, MD?

Tedicare shows public-source Medicare data for Nitin B. Chandramouli, MD (NPI 1801845730), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nitin B. Chandramouli, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nitin B. Chandramouli, MD?

Nitin B. Chandramouli, MD is linked to UTAH CANCER SPECIALISTS PC (billing NPI 1619925369) in the available physician profile data.

Does Nitin B. Chandramouli, MD have Open Payments data?

Nitin B. Chandramouli, MD has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.